AACR Richard and Hinda Rosenthal Memorial Award

Dr. Todd R. Golub (left) delivered his Award lecture entitled, "Genomic Information in Cancer," at the AACR 100th Annual Meeting 2009 in Denver, CO. He received the Award from Dr. Charles L. Sawyers (right), Selection Committee Chairperson.

• Learn more about the 2009 Recipient, Dr. Todd R. Golub.
• The webcast of the Award lecture may be accessed here. 
• View the list of all past Recipients. 

The Award and Lecture

The AACR and the Rosenthal Family Foundation established this Award in 1977 to recognize research that has made, or promises to soon make, a notable contribution to improved clinical care in the field of cancer. In its desire to honor and provide incentive to investigators relatively early in their careers, the Foundation has stipulated that recipients not be more than 50 years of age at the time the Award is received.

The winner of the 34th Annual AACR Richard and Hinda Rosenthal Memorial Award will receive an honorarium of $10,000 and give a 50-minute lecture during the 2010 AACR Annual Meeting in Washington, DC, U.S.A. (April 17-21, 2010).

Eligibility

• Candidacy is open to cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Such institutions include those in academia, industry, or government.
• The Award will be presented to an individual investigator.
• Institutions or organizations are not eligible for the Award.
• Candidates must not be more than 50 years of age at the time the Award is received. For the 2010 Award, a candidate's date of birth must be on or after April 21, 1959.
• Candidates must be engaged in the practice of medicine.
  

Nomination Process

Nominations for the 2010 Award will open August of 2009.

Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.

Nominations must be submitted online at https://proposalcentral.altum.com, no later than 4:00 p.m. United States Eastern Time on Thursday, October 15, 2009. Paper nominations will not be accepted. The following materials must be submitted:

Nomination Letter, which must:

• be addressed to the Selection Committee; be written in English; and not exceed 1,000 words;
• specify the AACR Award for which the candidate is being nominated;
• a concise description of the candidate's research that has made, or promises to soon make, a notable contribution to improved clinical care in the field of cancer, with the publications supporting these accomplishments directly referenced within the letter; and
• a concise description of the impact of these accomplishments on the field.

Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications.

Summary Statement. A statement, no more than 50 words, summarizing the candidate's research accomplishments for which he or she is being nominated.

Preferred file formats are *.doc. The candidate's CV may be submitted as a .pdf file. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within two business days. 

Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.

Nomination Instructions

Will be available in August 2009.

Selection

Candidates will be considered by a Committee of international cancer leaders appointed by the President of the AACR. After careful deliberations by the Award Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the Award winner will be made on the basis of the candidate's contribution to improved clinical care in the field of cancer. No regard will be given to race, gender, nationality, or religious or political views.  

Supporter

Generously supported by the Rosenthal Family Foundation.

Questions?

Monique P. Eversley, Program Associate
+1 (267) 646-0576; monique.eversley@aacr.org

American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA  19106-4404